PNC Pharma Ltd - Filleted accounts

Registered number

SC373472

PNC Pharma Ltd

Filleted Accounts

28 February 2026

PNC Pharma Ltd
Registered number:		SC373472
Balance Sheet
as at 28 February 2026

Notes			2026			2025
£				£
Fixed assets
Tangible assets	3		9,457			12,246
Investments	4		34,000			34,000
			43,457			46,246

Current assets
Stocks		51,860			77,600
Debtors	5	222,179			239,078
Cash at bank and in hand		78,276			44,253
		352,315			360,931

Creditors: amounts falling due within one year	6	(201,526)			(198,922)

Net current assets			150,789			162,009

Total assets less current liabilities			194,246			208,255

Creditors: amounts falling due after more than one year	7		-			(17,500)

Provisions for liabilities			(2,364)			-

Net assets			191,882			190,755

Capital and reserves
Called up share capital			100			100
Profit and loss account			191,782			190,655

Shareholder's funds			191,882			190,755

The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




Habib Khan
Director
Approved by the board on 3 June 2026

PNC Pharma Ltd
Notes to the Accounts
for the year ended 28 February 2026

1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Fixtures, fittings & office equipment	25% Straight line

	Investments
	Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.


	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Provisions
	Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.

	Pensions
	Contributions to defined contribution plans are expensed in the period to which they relate.


2	Employees		2026		2025
Number				Number

	Average number of persons employed by the company		12		15


3	Tangible fixed assets
					Fixtures, fittings & office equipment
£
	Cost
	At 1 March 2025				42,088
	Additions				6,367
	At 28 February 2026				48,455

	Depreciation
	At 1 March 2025				29,842
	Charge for the year				9,156
	At 28 February 2026				38,998

	Net book value
	At 28 February 2026				9,457
	At 28 February 2025				12,246


4	Investments
£
	Cost
	At 1 March 2025				34,000

	At 28 February 2026				34,000
	Investments comprise a time piece purchased from Watches of Switzerland at retail value.


5	Debtors		2026		2025
£				£

	Trade debtors		203,867		204,333
	Taxation and social security debtor		18,312		34,745
			222,179		239,078


6	Creditors: amounts falling due within one year		2026		2025
£				£

	Bank loans and overdrafts		8,334		-
	Trade creditors		176,934		188,394
	Accrued charges		617		600
	Taxation and social security costs		4,672		9,504
	Other creditors		10,969		424
			201,526		198,922


7	Creditors: amounts falling due after one year		2026		2025
£				£

	Bank loans		-		17,500


8	Other information

	PNC Pharma Ltd is a private company limited by shares and incorporated in Scotland. Its registered office is:
	c/o RX Pharmacy
	73A Lanark Road
	Carstairs
	Lanark
	ML11 8QL